南京新工投资集团有限责任公司
Search documents
南京化纤触发退市风险警示 “腾笼换鸟”能否扭转颓势?
Zhong Guo Jing Ying Bao· 2026-02-05 11:18
业绩承压 作为一家老牌化纤企业,南京化纤在2025年未能走出经营困境。 根据业绩预告,南京化纤预计利润总额亏损8000万元至1.2亿元;归母净利润亏损7400万元至1.11亿元; 扣除非经常性损益后的净利润亏损1.58亿元至2亿元。预计实现营业收入2.7亿元至3.3亿元,扣除与主营 业务无关的业务收入和不具备商业实质的收入后,营业收入仅为2.4亿元至2.9亿元,低于3亿元。 近日,南京化纤(600889.SH)披露2025年业绩预告,预计全年归母净利润亏损7000万元至1.1亿元。与 此同时,南京化纤还公告表示,依据《上海证券交易所股票上市规定》,公司股票可能被实施退市风险 警示。 目前,南京化纤正在筹划重大资产置换及发行股份购买资产计划,以改善经营状况。根据公告,南京化 纤计划置出持续亏损的化纤业务,置入南京工艺装备制造股份有限公司(以下简称"南京工艺")100% 股份,实现向高端装备制造转型。 根据公告,若南京化纤2025年度经审计的利润总额、净利润或者扣除非经常性损益后的净利润孰低者为 负值且营业收入低于3亿元,根据《上海证券交易所股票上市规则》第9.3.2条规定,其可能被实施退市 风险警示。 南京化纤 ...
A股罕见一幕,股东会选举董事,候选人会前突然“退出”,控股股东投出超20亿弃权票
Mei Ri Jing Ji Xin Wen· 2026-01-29 06:29
Group 1 - The core issue is that Yang Guohong, a candidate nominated by the controlling shareholder and its concerted parties, failed to be elected due to over 2 billion abstention votes, with only 5.36 million votes in favor, accounting for 2.4863% [1][2][4] - The successful candidates, Zhang Yan and Wang Qianliang, received over 2.1 billion votes each, with approval rates exceeding 99% [2][3] - The abstention votes were primarily cast by the controlling shareholder, Nanjing Zhongdian Panda Information Industry Group Co., Ltd., and its concerted parties, which included major shareholders [4][6] Group 2 - Yang Guohong voluntarily withdrew his candidacy for personal reasons, and the company could not amend the proposal due to the short notice before the meeting [1][7] - The company will initiate a supplementary election for the board of directors following this incident [1][4] - The company, as a central enterprise, focuses on the research, manufacturing, sales, and service of smart display terminal products, with a revenue of 38.894 billion yuan in the first three quarters of 2025 [8]
新工集团超2000万元专项基金精准激励引育用留,驱动高质量发展
Nan Jing Ri Bao· 2026-01-29 00:02
新工集团超2000万元专项基金精准激励引育用留,驱动高质量发展 开启人才"密钥" 激发"裂变反应" 为了让"产业头雁"既能放开手脚闯市场,又能共享发展红利,南京工艺参照新工集团长效激励与企业发 展深度绑定的模式推出项目"挂牌揭榜"制,鼓励人员"自建团队"踊跃揭榜,累计兑现"榜金"百余万元。 作为企业领航者,汪爱清带领南京工艺积极探索中长期激励机制,牵头建立超额利润分享模式,企业连 续3年达到分享条件并实施兑现,以良性激励机制推动企业持续盈利。 "一个人跑得快作用不大,要一群人跑得远。"在育才上汪爱清同样不遗余力。她针对科研人员及一线操 作人员,设立"首席"岗位,大胆起用"80后"技术骨干担任"首席",让能者揭榜,论功行赏。像江苏 省"333高层次人才"冯宇、江苏五一工匠培育对象李家喜这样的高技能人才纷纷涌现。 精准支持,厚植"科研尖兵"成长沃土 如果说领军人才是"开路人",那么科研人员就是"筑基者"。2025年12月30日,国家知识产权局公布"一 种氨基噻吩类化合物的制备方法"专利,金陵药业科研团队再次走到聚光灯下。这项技术将关键合成步 骤大幅缩短,效率提升显著。 "搞科研要耐得住寂寞。南京对科研人才的重视和 ...
南京医药集团股份有限公司2025年度第三期超短期融资券兑付公告
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2026-01-20 23:35
Group 1 - The company announced the successful payment of its third phase of super short-term financing bonds for 2025, ensuring the smooth execution of the payment process [1] - The bond payment will be made to the designated account of the bondholders on the payment date, with adjustments for public holidays [1] - The company emphasizes the importance of timely notification for any changes in the fund transfer path by bondholders to avoid delays in receiving funds [1] Group 2 - The company will hold its first extraordinary general meeting of shareholders in 2026 on February 5, 2026, at 14:00 [5] - Voting will be conducted through a combination of on-site and online methods, with specific time slots for online voting [6][7] - The meeting will discuss various resolutions, including special resolutions and those requiring abstention from related shareholders [9] Group 3 - The company has issued a total of 5 billion RMB in super short-term financing bonds in its second phase for 2026, with funds received on January 19, 2026, to be used for working capital and repaying bank loans [24] - The company has previously issued multiple phases of super short-term financing bonds, with the total amount of outstanding bonds yet to mature [22][23] Group 4 - The company has announced the achievement of conditions for the third release of restrictions on its 2021 stock incentive plan, allowing 324 participants to unlock 4.476712 million shares, representing 0.34% of the total share capital [25][36] - The company has followed all necessary procedures and received approvals for the stock incentive plan, ensuring compliance with relevant regulations [36][37] Group 5 - The company has disclosed its expected daily related transactions for 2026, which will exceed 30 million RMB and require shareholder approval due to the amount exceeding 5% of the latest audited net assets [41][43] - The related transactions are deemed necessary for the company's operations and will be conducted at market prices, ensuring no harm to the company's interests [41][51]
金陵药业股份有限公司 关于召开2026年第一次临时股东会的通知
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2026-01-20 23:35
登录新浪财经APP 搜索【信披】查看更多考评等级 一、召开会议的基本情况 (一)股东会届次:2026年第一次临时股东会 (二)股东会的召集人:董事会 金陵药业股份有限公司 (四)会议时间: 1、现场会议时间:2026年2月5日14:30 关于召开2026年第一次临时股东会的通知 (三)本次会议的召集、召开符合《中华人民共和国公司法》《深圳证券交易所股票上市规则》《深圳 证券交易所上市公司自律监管指引第1号一一主板上市公司规范运作》等法律、行政法规、部门规章、 规范性文件及《公司章程》的有关规定。 证券代码:000919 证券简称:金陵药业 公告编号:2026-004 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗 漏。 ■ 2、网络投票时间:通过深圳证券交易所系统进行网络投票的具体时间为2026年2月5日9:15-9:25,9:30- 11:30,13:00-15:00;通过深圳证券交易所互联网投票系统投票的具体时间为2026年2月5日9:15至15:00 的任意时间。 (五)会议的召开方式:现场表决与网络投票相结合。 (六)会议的股权登记日:2026年1月30日 ...
南京证券增资至44亿,增幅约19%
Xin Lang Cai Jing· 2026-01-16 05:57
Group 1 - The core point of the article is that Nanjing Securities has increased its registered capital from approximately 3.686 billion RMB to about 4.4 billion RMB, representing a growth of around 19% [1] - Nanjing Securities Co., Ltd. was established in November 1990 and is involved in various financial services including securities brokerage, investment consulting, and underwriting [1] - The shareholders of Nanjing Securities include Nanjing Zijin Investment Group Co., Ltd., Nanjing New Industry Investment Group Co., Ltd., and Nanjing Transportation Construction Investment Holding Group Co., Ltd. [1]
今年锁定老门东!南京新年首场人才夜市吸引近三千人“赶集”
Xin Lang Cai Jing· 2026-01-09 15:37
Group 1 - The event "Nanjing Talent Night Market" was held on January 9, 2026, attracting nearly 3,000 job seekers with over 2,300 positions offered by more than 50 employers across various industries including software, smart manufacturing, and hospitality [1][10] - The innovative recruitment model aims to provide a more flexible and engaging job-seeking experience, integrating talent recruitment with nighttime social activities [11] - The event featured five functional areas, including a recruitment zone, policy consultation area focusing on new talent policies, and an interactive cultural display, enhancing the overall experience for job seekers [10] Group 2 - Nanjing Big Data Group offered 9 types of positions, planning to hire 21 individuals, with salaries for popular roles like model engineers ranging from 200,000 to 300,000 yuan annually [5] - Nanjing New Industrial Investment Group presented 22 positions, aiming to recruit 31 people, with competitive salaries for roles such as AI algorithm engineers and operations engineers also in the range of 200,000 to 300,000 yuan [7][8] - The event's success exceeded expectations, with many resumes received matching job requirements, indicating a positive response from both employers and job seekers [8]
南京化纤:拟置入资产评估值16.07亿元
Xin Lang Cai Jing· 2025-12-29 14:00
南京化纤公告,公司拟通过资产置换、发行股份及支付现金的方式购买南京工艺装备制造股份有限公司 100%股份。根据江苏华信资产评估有限公司出具的评估报告,南京化纤截至评估基准日(2024年12月 31日)的全部资产及负债评估值为7.29亿元,南京工艺100%股份评估值为16.07亿元。交易价格分别为 7.29亿元和16.07亿元。交易对方包括南京新工投资集团有限责任公司、南京新工并购股权投资基金合伙 企业等。同时,南京化纤拟向包括新工集团在内的不超过35名特定投资者募集配套资金,总额不超过 4.4亿元。 ...
南京医药:关于公司参与设立南京新工南药医疗器械强链并购股权投资有限责任公司并对外投资暨关联交易的公告
Zheng Quan Ri Bao· 2025-12-18 13:17
Core Viewpoint - Nanjing Medical Pharmaceutical Company plans to invest in a new medical device investment company, indicating a strategic move to enhance its investment portfolio in the healthcare sector [2] Group 1: Investment Details - The company intends to invest 11.98 million RMB, which represents 59.9% of the total subscribed capital of the newly established Nanjing New Industry Medical Device Investment Company [2] - The investment will specifically target Ningbo Jiangfeng Biological Information Technology Co., Ltd., with an overall valuation not exceeding 750 million RMB for the acquisition of approximately 22.5% equity [2] - The final transaction price and key investment terms will be determined by a formal equity investment agreement [2] Group 2: Related Parties and Governance - The investment involves related parties, as Nanjing New Industry Investment Group Co., Ltd., the controlling shareholder of the company, fully owns Nanjing New Industry Investment Management Co., Ltd. [2] - The investment has been approved by the company's board of directors and does not require shareholder meeting approval [2]
南京国资新设医疗健康强链并购股权投资基金,出资额8亿
Sou Hu Cai Jing· 2025-12-15 06:05
Group 1 - Nanjing Xingu Medical Health Strong Chain M&A Equity Investment Fund Partnership has been established with a capital contribution of 800 million yuan [1][2] - The fund's business scope includes equity investment, private equity fund management, investment management, and asset management activities [1][2] - The fund is jointly funded by Nanjing Xingu Investment Group Co., Ltd., which is under the supervision of the Nanjing Municipal Government State-owned Assets Supervision and Administration Commission [1] Group 2 - The executing partner of the fund is Nanjing Xingu Emerging Industry Investment Management Co., Ltd. [2][3] - The fund is registered as a limited partnership and is currently in a state of existence [2] - The registered office is located in Jianye District, Nanjing, Jiangsu Province [2]